Daily Bulletin

Men's Weekly

.

New data independently confirms and extends laboratory findings and expands safety profile of ATH434-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

MELBOURNE, Australia and SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of...

Read more: New data independently confirms and extends laboratory findings and expands safety profile of...

More Articles ...

  1. Tile™ and Skullcandy Create Most Advanced True Wireless Finding Experience-PR Newswire APAC
  2. Trade360 Announces New Trading Platform-PR Newswire APAC
  3. Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report-PR Newswire APAC

Business News

Boost Your Career with Industry-Recognised Training Courses at Safety Australia Training

When it comes to workplace safety and professional development, Safety Australia Training stands out as one of the leading Registered Training Organisations (RTOs) in Australia. Whether you’re startin...

Daily Bulletin - avatar Daily Bulletin

Digital Marketing Agency in Sydney: Empowering Businesses with Smart Online Growth Strategies

Sydney’s business scene is fast-paced, diverse, and incredibly competitive. In such a dynamic environment, having a strong online presence is no longer optional — it’s essential. A digital marketing...

Daily Bulletin - avatar Daily Bulletin

Why Your Business Might Already Be a Cybercrime Target Without Knowing It

Cybercrime isn’t just something that happens to banks or large technology companies. It can happen to any business, even those that seem too small to matter. When a hacker sees an easy target, they ta...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business